RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP
Delisted
RVLP was delisted on the 20th of October, 2023.
36 hedge funds and large institutions have $21.6M invested in RVL Pharmaceuticals plc Ordinary Shares in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$313K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$171K |
| 3 |
Morgan Stanley
New York
|
+$96.4K |
| 4 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
+$83K |
| 5 |
Bank of New York Mellon
New York
|
+$83K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$1.05M |
| 2 |
NC
Nexthera Capital
New York
|
-$935K |
| 3 |
BC
Broadfin Capital
New York
|
-$794K |
| 4 |
Millennium Management
New York
|
-$321K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$209K |
